Intech Investment Management LLC Has $4.62 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Intech Investment Management LLC lifted its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 14.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,370 shares of the company's stock after purchasing an additional 3,615 shares during the quarter. Intech Investment Management LLC's holdings in Clorox were worth $4,622,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Advisors Asset Management Inc. lifted its position in Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company's stock valued at $1,719,000 after acquiring an additional 8,087 shares in the last quarter. Catalyst Capital Advisors LLC bought a new stake in Clorox in the 3rd quarter valued at $54,000. Raymond James & Associates lifted its position in Clorox by 32.8% in the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company's stock valued at $36,524,000 after acquiring an additional 66,149 shares in the last quarter. M&G Plc bought a new stake in Clorox in the 2nd quarter valued at $876,000. Finally, Cetera Investment Advisers lifted its position in Clorox by 140.6% in the 1st quarter. Cetera Investment Advisers now owns 74,032 shares of the company's stock valued at $11,335,000 after acquiring an additional 43,265 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.57% of the company's stock.

Clorox Stock Performance

Shares of Clorox stock opened at $169.31 on Friday. The company has a market cap of $20.96 billion, a PE ratio of 58.99, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a 50 day moving average of $162.78 and a 200-day moving average of $148.43. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 EPS. The firm's revenue was up 27.0% compared to the same quarter last year. As a group, equities research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.88%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is currently 170.04%.

Analysts Set New Price Targets

CLX has been the topic of several research reports. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and boosted their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and boosted their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays boosted their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research note on Friday, November 1st. Finally, DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Clorox has an average rating of "Hold" and an average price target of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.